Contents
Download PDF
pdf Download XML
823 Views
303 Downloads
Share this article
Review Article | Volume 2 Issue 2 (July-Dec, 2021) | Pages 1 - 4
Role of Homocysteine in Cardiovascular Pathology: How Much is it Useful in Detecting an Early Event of Acute Coronary Syndrome? A Study in a Tertiary Medical College of North India
 ,
1
Department of Medicine, Dr RPGMC Kangra Himachal Pradesh, India
2
Department of Pharmacology, Dr RPGMC Kangra, Himachal Pradesh, India
Under a Creative Commons license
Open Access
Received
Aug. 13, 2021
Revised
Oct. 11, 2021
Accepted
Oct. 30, 2021
Published
Nov. 10, 2021
Abstract

Cardiovascular system consists of three components: heart, blood vessels and blood, and participates in maintaining of internal body homeostasis in many aspects: transport of oxygen, carbon dioxide, nutrients, metabolism waste products, and hormones to and from every single cell in the body. The blood vessels are composed of three separated layers: intima, media and adventitia. The intima consists of single layer of endothelial cells that have crucial role in regulation of blood flow. Media is dominantly composed of vascular smooth muscle cells, and represents the thickest layer. The adventitia is outer layer made of connective and fat tissue that have protective role of other inner layers. Blood vessels differ depending on part of circulation to which it belongs (arterial, capillary or venous), or of specific needs and functions of tissues and organs in which it is located.

Keywords
INTRODUCTION:

Blood vessels are actively involved in the regulation of blood pressure and blood flow by summarizing the effects of the autonomic nervous system, various hormones and endothelial derived factors on changes of diameter. The vascular dilatation caused by shear stress of the blood is mediated by production of endothelium-derived relaxing factor – nitric oxide (NO) [1]. NO is synthesized by NO synthase and diffuses through cell membranes to the vascular smooth muscle cells, increases production of cyclic GMP and induces the relaxation.

 

Hyperhomocysteinemia (HHcy) is used as a predictive risk factor for cardiovascular disorders, the stroke progression, screening for inborn errors of Met metabolism, and as a supplementary test for vitamin B12 deficiency [2]. Hyperhomocysteinemia is associated with production of different ROS: superoxide anion (O2-), hydroxyl radical (OH), peroxynitrite (ONOO-), hydrogen peroxide (H2O2), as well as other peroxides and hypochlorous acid, and their organic analogues [3]. Within the investigation where the coronary and mesenteric arteries were incubated with methionine it has been revealed the role of angiotensin- converting enzyme (ACE) and angiotensin II (ANGII) signaling pathway in activation of NADPH oxidase and increase in O2production [4]. The link between ACE, ANGII signaling and NADPH oxidase have been noticed earlier, but in this study it was described the role of homocysteine in activation of ACE [5]. Namely, homocysteine induces homocysteinylation of ACE, which in turn has greater activity of this enzyme, followed by increased transduction by ACE/ANG II/AT1R signaling pathway, and of and of O2-.

 

On the other hand, homocysteine induces increased expression of different forms of NADPH oxidase. NOX4 is an isoform of NADPH oxidase highly represented in the kidney, and incubation of tubular cells with homocysteine showed increased production of O2- [6]. Proposed underlying mechanism was incrementing the expression of NOX4 by homocysteine. Increased production of O2leads to decreased bioavailability of nitric oxide (NO), due to reaction of these two molecules and production of highly reactive peroxynitrite (ONOO-). NO is synthesized by three isoforms of enzyme nitric oxide synthase (NOS): endothelial NOS (eNOS or NOSI), inducible NOS (iNOS or NOSII) and neuronal NOS (nNOS or NOS III). eNOS and nNOS are constitutive enzymes and their activity is regulated by changes in Ca2+ content in the cytoplasm. All three isoforms generate NO from L-arginine in the presence of O2 and NADPH. Also as cofactors are necessary flavin mononucleotide (FMN), flavin adenine dinucleotide (FAD), and tetrahydrobiopterin (BH4). BH4 is crucial for NOS function because it binds NOS monomers to form dimers which contain two reductase domains ‘coupled’ to another pair of oxygen domains. NOS monomers generate O2instead of NO, and this ‘uncoupled’ enzyme represents a ROS producer. The classical signaling pathway of NO includes activation of soluble guanylyl cyclase and production of cyclic guanosine 3’,5’-monophosphate (cGMP). NO acts in autocrine or paracrine manner. In study on HUVECs increased homocysteine induced decrement in NO production, and also an increase in production of endothelin-1 (ET-1), as one of the most potent vasoconstrictors. On the other hand homocysteine can increase production of NO by upregulating iNOS by proinflammatory cytokines, whose synthesis is amplified by homocysteine. But in these conditions homocysteine induces increased expression of iNOS, and increment of O2production by uncoupling of iNOS. [7]

 

Recently, it has been indicated as a potentially new mechanism involved in Hcy induced changes in cardiovascular system (CVS) which implies Toll-like receptor 4 (TLR4). TLR4 belongs to the Toll-like receptor (TLR) family, and their roles in pathogenesis of CVD are intensively studied. Namely, TLR4, that normally play a role in the innate immune response and recognize viral or bacterial antigen motifs, are expressed in almost all cells represented in CVS [8] and participate in pathogenesis of atherosclerosis [9], ischemic heart disease [10], heart failure [11] or aorta aneurysm [12]. Results of Jeremic and colleagues indicates that ablation of TLR4 in HHcy mice diminish changes induced by increased levels of Hcy such as left ventricular hypertrophy, increased oxidative stress and decreased antioxidative capacity, and mitochondrial  fission [13]. Same authors provided results on the basis of which it can be concluded that TLR4 during HHcy mediate in predominance of mitochondrial fission in endothelial cells, and consequent oxidative stress, endothelial cell loss and dysfunction, increased collagen deposition, which ultimately causes hypertension [14]. On the other hand, mutation of TLR4 alleviated vascular inflammation and prevented hypertension [15]. Molecular mechanisms and signaling pathways involved in above mentioned changes in CVS induced by HHcy trough TLR4 are probably same or similar to those that exist in other cells and tissues. Intracellular domain of TLR4, Toll/interleukin-1 receptor (TIR) domain, activates several adapter proteins such as: myeloid differentiation primary response gene 88 (MyD88), Toll-Interleukin I receptor domain-containing adaptor protein (TIRAP), TIR domain-containing adaptor protein inducing interferon-b (TRIF), TRIF-related adaptor molecule (TRAM), which actually represents the first step of TLR signal transduction [16]. MyD88 further engages IL-1R-associated kinases (IRAKs) which initiate activation of nuclear factor kappa light-chain-enhancer of activated B cells (NF-κB) and production of cytokines. Another, TRIF pathway, requires TRAM, which through activation of several kinases (receptor-interacting serine/threonine-protein 1 (RIP-1) kinase and transforming growth-factor-b-activated kinase 1 (TAK-1)) activates NF-κB and mitogen-activated protein kinase (MAPK), and overall result is increment of expression of proinflammatory genes and synthesis of inflammatory cytokines. [17]

 

Effects of Hcy and its different forms on heart, coronary circulation and heart tissue oxidative balance were intensively investigated by Jakovljevic and Djuric. In study dealing with correlation between plasma total Hcy (tHcy) level and coronary atherosclerosis, it has been shown that tHcy was significantly higher in patients with angiographically confirmed coronary artery disease (CAD) compared to healthy control [18]. Besides that, in groups of patients with CAD, levels of tHcy more frequently exceeded the value of 15 mmol/l, which was also more common with older people, and there was positive correlation between increased tHcy level and uric acid level. In a study that examined the effects of various Hcy-related compounds (DL-Hcy, DL-Hcy Thiolactone-hydrochloride (TLHC) and L-Hcy TLHC) the authors emphasized their harmful effects on cardiac function during acute administration in an isolated rat heart [19]. During acute application of DL-Hcy TLHC simultaneous inhibition of production of the gasotransmitters (NO, H2S and CO) additionally exacerbated the effects of DL-Hcy TLHC [20]. The inhibition of CO production expressed most deleterious effects in comparison to deprivation of NO and H2S production. Furthermore, results of another investigation showed protective effects of H2S in changes induced by DL-Hcy [21]. Namely, application of DL-propargylglycine, as an inhibitor of H2S formation, decreased all cardio-dynamic parameters and increased the concentration of O2-, which was even more pronounced with the simultaneous application with DL-Hcy, which leads to the conclusion that DL-Hcy shows a lower pro-oxidative effect in the presence of H2S. It is also shown that previously mentioned Hcy-related compounds (DL-Hcy, DL-Hcy TLHC and L-Hcy TLHC) impair oxygen consumption of rat heart tissue homogenate, as well as the inclusion of the gasotransmitters NO, H2S and CO in these effects. [22]

 

Bearing in mind that inflammation is important factor in pathogenesis of cardiovascular diseases, a certain number of papers dealt with role of Hcy in induction of inflammation and showed that HHcy is accompanied with upregulation of several pro-inflammatory cytokines, including IL-1β, IL-6, TNF-α, MCP-1, and intracellular adhesion molecule-1. NMDA receptors are also present in almost all blood cells so that their activation may have various effects on the signaling pathways in these cells. Activation of NMDA receptors in red blood cells (RBC) induces increase in Ca2+ content and thus changes properties of RBCs such as cell volume, membrane steadiness, and capacity to transfer O2 [23]. 

 

On the other hand, Reinhart and coworkers indicated that neither activation nor inhibition has any influence on biophysical properties of RBCs, such as deformability and aggregability parameters [24]. Namely, treatment of RBCs with homocysteic acid, and combination of memantine and homocysteic acid did not change any of the observed parameters. Bearing in mind that plasma concentrations of Hcy in healthy population are below 15 μmol/l, in cases of severe HHcy, when Hcy concentration exceeds 100 μmol/l, homocysteine and homocysteic acid probably have a dominant role in the regulation of NMDA receptor activity in the blood cells [25]. The presence of the NMDA receptors in several types of immune competent cells was also confirmed, suggesting their role in regulation of immune response and inflammation. Similar to the aforementioned mechanisms in other types of cells, activation of NMDA receptors by homocysteine or homocysteic acid in cells of immune system induces Ca2+ accumulation, and consequent increase of reactive species production and oxidative stress, and activation of MAPK [26]. Activation of neutrophils causes increased expression of NMDA receptors on their membranes, so in the conditions of HHcy neutrophils generate large amounts of ROS and easier to undergo the degradation process [27]. These changes produce proinflammatory environment and enhance the production of pro-inflammatory cytokines such as TNF-α, interleukin-1β and interleukin-6 in neutrophils, monocytes or macrophages via NF-κB, ERK, and P2X7 stimulation [28]. Augmented production of pro- inflammatory cytokines and activation of immune cells activates both necrotic and apoptotic cell death. Platelets also express NMDA receptors, and results of several studies suggest their significant role in the functioning of platelets. NMDA receptor antagonists, such as MK-801 and memantine, induce inhibition on platelet aggregation and activation, while NMDA receptor agonists increase aggregation in the presence of low concentrations ADP with an increase in Ca2+ content in platelets [29]. In accordance with the above fact, it has been shown that Hcy causes an increase in whole blood platelet aggregation, as well as in production of O2-. Antagonists of NMDA receptors induced reduced increment of platelet aggregation induced by Hcy, while increased production of O2remained unchanged, suggesting other possible mechanisms involved, independent of Ca2+ entry. [30]

CONCLUSION:

As an integral component of several disorders including cardiovascular and cerebrovascular diseases, neurodegeneration, liver steatosis, hyperhomocysteinemia can result from deficiencies of vitamin cofactors (B6, B12, folic acid) required for Hcy metabolism and/or from genetic disorders of its metabolism. This review provides evidence that supports the causal role for HHcy in the development of CVD and nervous system disorders, and outlines several cellular and molecular mechanisms by which Hcy induces disorders of the function of these two organic systems. These mechanisms include oxidative stress, inflammation, ER stress, DNA hypomethylation, homocysteinylation, Hcy Thiolactone levels and mitochondrial dysfunction. In the future, further studies are much needed to provide more convincing evidence demonstrating the pathogenic role of HHcy in the progression of CVD and nervous system disorders in animal studies and clinical studies. Beside mentioned facts, it remains to be examined whether Hcy is a causative agent or marker of damage. 

 

Funding: No funding sources.

 

Conflict of interest: None declared.

 

Ethical approval: The study was approved by the Institutional Ethics Committee of Dr RPGMC Kangra, Himachal Pradesh.

 

REFERENCES:
  1. Gutterman DD, Chabowski DS, Kadlec AO, Durand MJ, Freed JK, Ait-Aissa K, Beyer AM. The human microcirculation: regulation of flow and beyond. Circulation research. (2016) Jan 8;118(1):157-72. doi: 10.1161/CIRCRESAHA PMID: 26837746
  2. Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D'Agostino RB, Wolf PA, Jacques PF, Wilson PW. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Archives of Internal Medicine. (1999) May 24;159(10):1077-80. PMID: 10335684
  3. Papatheodorou L, Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxidants & redox signaling. (2007) Nov 1;9(11):1941-58. doi: 10.1089/ars.2007.1750 PMID: 17822365
  4. Huang A, Pinto JT, Froogh G, Kandhi S, Qin J, Wolin MS, Hintze TH, Sun D. Role of homocysteinylation of ACE in endothelial dysfunction of arteries. American Journal of Physiology-Heart and Circulatory Physiology. (2015) Jan 15;308(2):H92-100. doi: 10.1152/ajpheart.00577.2014 PMID: 25416191
  5. Huang A, Yang YM, Feher A, Bagi Z, Kaley G, Sun D. Exacerbation of endothelial dysfunction during the progression of diabetes: role of oxidative stress. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. (2012) Mar 15;302(6):R674-81. doi: 10.1152/ajpregu.00699.2011 PMID: 22262308
  6. Hwang SY, Siow YL, Au-Yeung KK, House J, O K. Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney. American Journal of Physiology-Renal Physiology. (2011) Jan;300(1):F189-98. doi: 10.1152/ajprenal.00272.2010 PMID: 20980407
  7. Duan J, Dai S, Fang CX, Sun R, Shavali S, Sharma SK, Ebadi M, Ren J. Phytoestrogen α-zearalanol antagonizes homocysteine-induced imbalance of nitric oxide/endothelin-1 and apoptosis in human umbilical vein endothelial cells. Cell biochemistry and biophysics. (2006) Jun;45(2):137-45. doi: 10.1385/CBB:45:2:137 PMID: 16757814
  8. Becher PM, Hinrichs S, Fluschnik N, Hennigs JK, Klingel K, Blankenberg S, Westermann D, Lindner D. Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor. PloS one. (2018) Mar 14;13(3):e0193844. doi: 10.1371/journal.pone.0193844 PMID: 29538462
  9. Wijnand K, Cheng C, Pasterkamp G, Duckers HJ. Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis. (2010) Apr 1;209(2):314-20. doi: 10.1016/j.atherosclerosis.2009.09.075 PMID: 19900676.
  10. Satoh S, Yada R, Inoue H, Omura S, Ejima E, Mori T, Takenaka K, Kawamura N, Numaguchi K, Mori E, Asoh A. Toll-like receptor-4 is upregulated in plaque debris of patients with acute coronary syndrome more than Toll-like receptor-2. Heart and vessels. (2016) Jan 1;31(1):1-5. doi: 10.1007/s00380-014-0565-9 PMID: 25179298
  11. Liu L, Wang Y, Cao ZY, Wang MM, Liu XM, Gao T, Hu QK, Yuan WJ, Lin L. Up‐regulated TLR 4 in cardiomyocytes exacerbates heart failure after long‐term myocardial infarction. Journal of cellular and molecular medicine. (2015) Dec;19(12):2728-40. doi: 10.1111/jcmm.12659 PMID: 26290459
  12. Lai CH, Wang KC, Lee FT, Tsai HW, Ma CY, Cheng TL, Chang BI, Yang YJ, Shi GY, Wu HL. Toll-like receptor 4 is essential in the development of abdominal aortic aneurysm. PLoS One. (2016) Jan 7;11(1):e0146565. doi: 10.1371/journal.pone.014656 PMID: 26741694
  13. Jeremic N, Weber GJ, Tyagi SC. Ablation of toll-like receptor 4 mitigates cardiac mitochondrial dysfunction in hyperhomocysteinemia. Canadian journal of physiology and pharmacology. (2017);95(11):1369-75. doi: 10.1139/cjpp-2016-0744 PMID: 28738166
  14. Jeremic N, Weber GJ, Familtseva A, Metreveli N, Tyagi SC. Ablation of Toll-like receptor 4 mitigates central blood pressure response during hyperhomocysteinemia. Journal of hypertension. (2017) Nov 1;35(11):2226-37. doi: 10.1097/HJH.0000000000001460 PMID: 28665886
  15. Familtseva A, Chaturvedi P, Kalani A, Jeremic N, Metreveli N, Kunkel GH, Tyagi SC. Toll-like receptor 4 mutation suppresses hyperhomocysteinemia-induced hypertension. American Journal of Physiology-Cell Physiology. (2016) Oct 1;311(4):C596-606. doi: 10.1152/ajpcell.00088.2016 PMID: 27488663. Ferechide D, Radulescu D. Hyperhomocysteinemia in renal diseases. Journal of medicine and life. 2009 Jan 1;2(1):53-9. PMID: 20108491
  16. Goulopoulou S, McCarthy CG, Webb RC. Toll-like receptors in the vascular system: sensing the dangers within. Pharmacological reviews. (2016) Jan 1;68(1):142-67. doi: 10.1124/pr.114.010090 PMID: 26721702
  17. De Nardo D. Toll-like receptors: activation, signalling and transcriptional modulation. Cytokine. 2015 Aug 1;74(2):181-9. doi: 10.1016/j.cyto.2015.02.025 PMID: 25846205
  18. Mitrovic V, Djuric D, Petkovic D, Hamm C. Evaluation of plasma total homocysteine in patients with angiographically confirmed coronary atherosclerosis: possible impact on therapy and prognosis. PERFUSION-MUNICH THEN NURNBERG-. (2002) Jan 1;15(1):10-8.
  19. Zivkovic V, Jakovljevic V, Djordjevic D, Vuletic M, Barudzic N, Djuric D. The effects of homocysteine-related compounds on cardiac contractility, coronary flow, and oxidative stress markers in isolated rat heart. Molecular and cellular biochemistry. (2012) Nov;370(1):59-67. doi: 10.1007/s11010- 012-1398-4. PMID: 22821198. Res. Int. 2013: 318471. doi: 10.1155/2013/318471. PMID: 24350259
  20. Zivkovic V, Jakovljevic V, Pechanova O, Srejovic I, Joksimovic J, Selakovic D, Barudzic N, Djuric DM. Effects of DL-homocysteine thiolactone on cardiac contractility, coronary flow, and oxidative stress markers in the isolated rat heart: the role of different gasotransmitters. BioMed research international. (2013) Jan 1;2013.
  21. Stojanović M, Šćepanović L, Hrnčić D, Rašić-Marković A, Djurić D, Stanojlović O. Multidisciplinary approach to nitric oxide signaling: Focus on the gastrointestinal and the central nervous system. Vojnosanitetski pregled. (2015) Jun 30;72(7):619-24. doi: 10.2298/VSP131025051S PMID: 26364456
  22. Uzelac JJ, Stanić M, Krstić D, Čolović M, Djurić D. Effects of homocysteine and its related compounds on oxygen consumption of the rat heart tissue homogenate: the role of different gasotransmitters. Mol. Cell. Biochem. (2017). doi: 10.1007/s11010-017-3238-z PMID: 29188533.
  23. Makhro A, Kaestner L, Bogdanova A. NMDA receptor activity in circulating red blood cells: methods of detection. InNMDA Receptors (2017);265-282:1677. Humana Press, New York, NY. doi: 10.1007/978-1- 4939-7321-7_15 PMID: 28986879
  24. Reinhart WH, Geissmann-Ott C, Bogdanova A. Activation of N-methyl D-aspartate (NMDA) receptors has no influence on rheological properties of erythrocytes. Clinical hemorheology and microcirculation. (2011) Jan 1;49(1-4):307-13. doi: 10.3233/CH-2011-1481 PMID: 22214702
  25. Adragna NC. Homocysteine: to measure or not to measure? Focus on “Functional NMDA receptors in rat erythrocytes”. American Journal of Physiology-Cell Physiology. (2010) Jun;298(6):C1301-2. doi:10.1152/ajpcell.00111.2010 PMID: 20357186.
  26. Boldyrev A, Bryushkova E, Mashkina A, Vladychenskaya E. Why is homocysteine toxic for the nervous and immune systems?. Current aging science. (2013) Feb 1;6(1):29-36. PMID: 23237596
  27. Bryushkova EA, Vladychenskaya EA, Stepanova MS, Boldyrev AA. Effect of homocysteine on properties of neutrophils activated in vivo. Biochemistry (Moscow). (2011) Apr;76(4):467-72. PMID: 21585323
  28. Zanin RF, Bergamin LS, Morrone FB, Coutinho-Silva R, de Souza Wyse AT, Battastini AM. Pathological concentrations of homocysteine increases IL-1β production in macrophages in a P2X7, NF-ĸB, and erk-dependent manner. Purinergic signalling. (2015) Dec;11(4):463-70. doi: 10.1007/s11302-015-9464-5 PMID: 26265456
  29. Kalev-Zylinska ML, Green TN, Morel-Kopp MC, Sun PP, Park YE, Lasham A, During MJ, Ward CM. N-methyl-D-aspartate receptors amplify activation and aggregation of human platelets. Thrombosis research. (2014) May 1;133(5):837-47. doi: 10.1016/j.thromres.2014.02.011 PMID: 24593912
  30. Karolczak K, Pieniazek A, Watala C. Inhibition of glutamate receptors reduces the homocysteine-induced whole blood platelet aggregation but does not affect superoxide anion generation or platelet membrane fluidization. Platelets. (2017)Jan 2;28(1):90-8. doi: 10.1080/09537104.2016.1204438 PMID: 27560773

     

Advertisement
Recommended Articles
Research Article
Anti-Ulcer Activity of Methanolic Extract of Alpinia Nigra Rhizome on Experimentallys Induced Gastric Ulceration in Albino Rats
...
Published: 30/06/2021
Download PDF
Research Article
Comparing the Morphometric Properties of Pseudoexfoliation Without Glaucoma Versus Pseudoexfoliation with Glaucoma: An Analytical Study in Sub-Himalayan Region
...
Published: 10/03/2021
Download PDF
Research Article
Retrospective Analysis of Histopathological Examination of Hysterectomy Specimens in A Tertiary Care Centre
...
Published: 20/07/2021
Download PDF
Research Article
A Critical Analysis of Spinal Block Anesthesia under Ultrasonographic Guided Technique: Is Levobupivacaine Alone Effective or on Adjuvant is Warranted?
Published: 20/09/2021
Download PDF
Chat on WhatsApp
Flowbite Logo
Najmal Complex,
Opposite Farwaniya,
Kuwait.
Email: kuwait@iarcon.org

Editorial Office:
J.L Bhavan, Near Radison Blu Hotel,
Jalukbari, Guwahati-India
Useful Links
Order Hard Copy
Privacy policy
Terms and Conditions
Refund Policy
Others
About Us
Contact Us
Online Payments
Join as Editor
Join as Reviewer
Subscribe to our Newsletter
Follow us
MOST SEARCHED KEYWORDS
scientific journal
 | 
business journal
 | 
medical journals
 | 
Scientific Journals
 | 
Academic Publisher
 | 
Peer-reviewed Journals
 | 
Open Access Journals
 | 
Impact Factor
 | 
Indexing Services
 | 
Journal Citation Reports
 | 
Publication Process
 | 
Impact factor of journals
 | 
Finding reputable journals for publication
 | 
Submitting a manuscript for publication
 | 
Copyright and licensing of published papers
 | 
Writing an abstract for a research paper
 | 
Manuscript formatting guidelines
 | 
Promoting published research
 | 
Publication in high-impact journals
Copyright © iARCON Internaltional LLP . All Rights Reserved.